References
- Bange A, Halsall HB, Heineman WR. (2005). Microfluidic immunosensor systems. Biosens Bioelectron 20:2488–503
- Bennett M, Dent CL, Ma Q, et al. (2008). Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephro 3:665–673
- Bonham M, Miller S. (2009). Clinical comparison of 99th percentile and 10% coefficient of variation cutoff values for four commercially available troponin I assays. Labmedicine 40:470–3
- Cavalier E, Bekaert A-K, Carlisi A, et al. (2011). Neutrophil gelatinase-associated lipcalin (NGAL) determined in urine with Abbott Architect or in plasma with the Biosite Triage? The laboratory point’s of view. Clin Chem Lab Med 49:339–41
- Cowland JB, Borregaard N. (1997). Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45:17–23
- Dent CL, Ma Q, Dastrala S, et al. (2007). Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 11:R127
- Devarajan P. (2007). Proteomics for biomarker discovery in acute kidney injury. Semin Nephrol 27:637–51
- Devarajan P. (2008). Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 241:89–94
- Devaraja P. (2010). Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 4:265–80
- Han WK, Bonventre JV. (2004). Biologic markers for the early detection of acute kidney injury. Curr Opin in Crit Care 10:476–82
- Hortin GL, Meilinger B. (2005). Cross-reactivity of amino acids and other compounds in the biuret reaction: interference with urinary peptide measurements. Clin Chem 51:1411–19
- Murray W, Peter TA, Teclaw RF. (1993). The clinical relevance of assay validation. Comp Cont Educ Pract 15:1665–75
- Naud J-F, Leblanc M. (2008). Biomarkers in acute kidney injury. Biomark Insights 3:115–25
- Sviridov D, Hortin GL. (2009). Urine albumin measurement: effects of urine matrix constituents. Clin Chim Acta 404:140–3
- Taylor TP, Janech MG, Slate EH, et al. (2012). Overcoming the effects of matrix interference in the measurement of urine protein analytes. Biomark Insights 7:1–8
- Vaidya VS, Ferguson MA, Bonventre JV. (2008). Biomarkers of acute kidney injury. Annu Rev Pharmacol 48:463–93
- Wingren C, Borrebaeck CAK. (2009). Antibody-based microarrays. In: Bilitewski U, ed. Microchip methods in diagnostics. New York: Humana, 57–84